Related Experiment Video
Updated: Aug 27, 2025
06:17
A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
12.0K
Free Gangliosides Can Alter Amyloid-β Aggregation.
Arghya Chakravorty1, Samuel D McCalpin2, Bikash R Sahoo2,3
1Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.
The Journal of Physical Chemistry Letters
|September 29, 2022
Summary
Free ganglioside GM1 inhibits amyloid-β40 aggregation but not amyloid-β42. This suggests GM1
Area of Science:
- Neuroscience
- Biochemistry
- Computational Biology
Background:
- Alzheimer's disease is characterized by amyloid-β (Aβ) peptide aggregates.
- The lipid-chaperone hypothesis proposes that free lipids influence Aβ aggregation.
- Neuronal ganglioside GM1 is abundant in mammalian brains.
Purpose of the Study:
- To investigate the effects of ganglioside GM1 on the aggregation of Aβ40 and Aβ42 isoforms.
- To explore the molecular interactions between GM1 and Aβ peptides using simulations and experiments.
Main Methods:
- All-atom molecular dynamics simulations in explicit solvent.
- Nuclear magnetic resonance (NMR) experiments.
- Thioflavin T fluorescence assays to assess aggregation.
Main Results:
- Free GM1 forms stable, water-soluble complexes with both Aβ40 and Aβ42.
- NMR confirms well-ordered, compact GM1+Aβ complexes.
- Aβ40 prefers GM1-containing hetero-oligomers; Aβ42 prefers GM1-lacking homo-oligomers.
- GM1 inhibits Aβ40 aggregation dose-dependently but not Aβ42 aggregation.
Conclusions:
- GM1's differential effects on Aβ40 and Aβ42 aggregation are explained by isoform-specific binding preferences.
- This study provides molecular insights into how lipids modulate amyloidogenic peptide aggregation.
- Findings support the lipid-chaperone hypothesis in the context of Alzheimer's disease pathogenesis.
